CXCR4 is a potential target for development of new anti-inflammatory drugs. A novel amide-sulfamide compound library was built for vHTS and additional screening. 30 amide-sulfamide compounds were obtained after ADMET and silico docking filtering against CXCR4. 12 selected compounds were synthesized and evaluated as CXCR4 modulators. Ig showed significantly anti-inflammatory activity both in vitro and in vivo.